Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 1, 2022
[Recent topics on interorgan communication networks and gut microbiota]Naoshige Ono, Yasu-Taka Azuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|August 14, 2019
[Recent progress in the pathophysiological role of interleukin-19]Yasuyuki Fujimoto, Yasu-Taka Azuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|September 2, 2021
[Therapeutic application utilizing the anti-inflammatory effect of IL-19]Naoshige Ono, Yasu-Taka Azuma
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 4, 2026
[The significance of IL-19 in the liver: crosstalk among inflammation, metabolism, and fibrosis]Yuko Mitani, Takashi Fujita, Yasu-Taka Azuma
The Journal of Veterinary Medical Science|July 12, 2026
The Na+/Ca2+ exchanger: molecular structure, functional regulation, and mode-selective modulationNaoshige Ono, Kazuhiro Nishiyama, Yasu-Taka Azuma
The Journal of Veterinary Medical Science|June 14, 2019
The clarified role of interleukin-19 in the inflammatory bowel disease and hypersensitivity: Insights from animal models and humansYasuyuki Fujimoto, Kimiya Aono, Yasu-Taka Azuma
Current Pharmaceutical Design|November 23, 2011
IL-19 as a potential therapeutic in autoimmune and inflammatory diseasesYasu-Taka Azuma, Hidemitsu Nakajima, Tadayoshi Takeuchi
The Journal of Veterinary Medical Science|August 12, 2020
Deficiency of interleukin-19 exacerbates lipopolysaccharide/D-galactosamine-induced acute liver failureYasuyuki Fujimoto, Mitsuru Kuwamura, Yasu-Taka Azuma
The Journal of Veterinary Medical Science|January 12, 2026
Interleukin-19 deficiency exacerbates inflammation and fibrosis in ethanol/lipopolysaccharide-induced chronic pancreatitisNaoshige Ono, Takashi Fujita, Kazuhiro Nishiyama, et al.
Pageof 8